Cargando…
Does Aromatase Inhibitors Cause Sjogren’s Syndrome and Polyneuropathy?
Aromatase inhibitors (AIs) are the indispensible part of hormone-responsive breast cancer treatment. A potential relation between autoimmunity and AIs has been described before. Herein, we report a case of Sjogren’s syndrome (SjS) and polyneuropathy which developed during treatment with anastrozole....
Autores principales: | Yasar Bilge, Nazife Sule, Korkmaz, Cengiz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649745/ https://www.ncbi.nlm.nih.gov/pubmed/29147400 http://dx.doi.org/10.14740/wjon695w |
Ejemplares similares
-
Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review
por: Şule Yaşar Bilge, Nazife, et al.
Publicado: (2022) -
Polyneuropathy as Novel Initial Manifestation in a Case of “Nonsecretory” POEMS Syndrome with Sjögren's Syndrome
por: Liang, Minrui, et al.
Publicado: (2017) -
Acute polyneuropathy as the main manifestation of primary Sjogren’s syndrome: A case report
por: Haj Mohamad Ebrahim Ketabforoush, Arsh, et al.
Publicado: (2022) -
Granulocyte-colony-stimulating Factor-resistant Neutropenia and Polyneuropathy Presenting as Severe Complications of Sjögren's Syndrome
por: Tomita, Katsuyuki, et al.
Publicado: (2022) -
A Challenging Diagnosis: A Case of Multisystem Inflammatory Syndrome Following COVID-19 Vaccination
por: Yıldırım, Reşit, et al.
Publicado: (2022)